Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Molecular biology: generality].

C Bastard1

  • 1Laboratoire de génétique oncologique, centre Henri-Becquerel, rue d'Amiens, 76038 Rouen, France. christian.bastard@rouen.fnclcc.fr

Pathologie-Biologie
|August 21, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell therapy for posttraumatic shoulder osteonecrosis.

Morphologie : bulletin de l'Association des anatomistes·2020
Same author

Return to sports and quality of life after high tibial osteotomy in patients under 60 years of age.

Orthopaedics & traumatology, surgery & research : OTSR·2017
Same author

A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?

Leukemia·2016
Same author

Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia.

Leukemia·2015
Same author

Transformation of an Unclassified Myeloproliferative Neoplasm with a Rare BCR-JAK2 Fusion Transcript Resulting from the Translocation (9;22)(p24;q11).

Case reports in hematology·2015
Same author

The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma.

Genes, chromosomes & cancer·2013
Same journal

Pathologie-biologie·2020
Same journal

Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

Pathologie-biologie·2015
Same journal

[Not Available].

Pathologie-biologie·2015
Same journal

Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

Pathologie-biologie·2015
Same journal

Biological diagnosis of diabetes mellitus.

Pathologie-biologie·2015
Same journal

Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

Pathologie-biologie·2015
See all related articles

Molecular analysis identifies genes and mechanisms driving hematologic malignancies. New PCR tools improve detection and patient monitoring for these cancers.

Area of Science:

  • Genetics
  • Molecular Biology
  • Oncology

Context:

  • Hematologic malignancies are cancers affecting blood, bone marrow, and lymph nodes.
  • Chromosomal abnormalities play a crucial role in the development of these cancers.
  • Understanding these abnormalities is key to diagnosing and treating blood cancers.

Purpose:

  • To identify genes and recurrent mechanisms involved in chromosomal abnormalities in hematologic malignancies.
  • To explore the utility of Polymerase Chain Reaction (PCR) alongside cytogenetic methods for detecting these abnormalities.

Summary:

  • Molecular analysis has identified specific genes and mechanisms, such as gene deregulation and fusion, driving tumoral processes in hematologic malignancies.
  • Conventional and molecular cytogenetics, complemented by PCR techniques, enable the detection and quantification of chromosomal rearrangements.

Related Experiment Videos

  • These advancements facilitate a more precise understanding of the molecular underpinnings of blood cancers.

    • Impact:

    • Improved identification of genes and mechanisms contributing to hematologic malignancies.
    • Enhanced diagnostic and monitoring capabilities through advanced PCR and cytogenetic tools.
    • Potential for more targeted therapies and better patient outcomes in blood cancer treatment.